Headshot of Resensation Breast Neurotization Surgeon Jessica Erdmann Sager MD

Jessica Erdmann-Sager , MD

Boston, MA

Brigham and Woman's Hospital

75 Frances St.
Boston, MA 02115

Brigham and Womens logo

Jessica Erdmann-Sager, MD

Jessica Erdmann-Sager, MD is a plastic surgeon and breast reconstruction specialist at Brigham and Women’s Hospital in Foxborough, Massachusetts. With expertise in reconstructive microsurgery of the breast, she offers numerous types of autologous (free flap) breast reconstruction, including the DIEP flap, DUG flap, PAP flap, SGAP flap and SIEA flap, to meet each patient’s unique needs after breast cancer and mastectomy.

Flap breast reconstruction uses a woman’s excess tissue, usually taken from the abdomen, buttocks, or inner thighs, to recreate breasts. To potentially restore sensation to the reconstructed breasts, Dr. Erdmann-Sager also offers Resensation®. Resensation is a surgical technique in which surgeons reattach nerves in the flap of tissue used to create breasts with nerves in the chest. A nerve allograft (donated nerve) bridges the gap between the nerves, and helps to support nerve regrowth. Over time, this may result in restored sensation.

Affiliated Hospitals

  • Brigham and Womens logo
Undergrad: Duke University
Medical Degree: Harvard Medical School
Residency: Beth Israel Medical Center and Columbia-Presbyterian Medical Center in New York

Resensation Blog

self-advocacy: how to communicate your cancer care needs

Self-advocacy is vital for communicating your cancer care needs, but it can be difficult. These tips will help you out.

Read More
How resensation helped one woman hold onto what matters most

Gwynne was religious about yearly mammograms, so when her OB-GYN said they found something, she was surprised and scared.

Read More
Resensation Your new normal
your new normal: preparing for life after treatment

Cancer patients long to hear the words “cancer free.” But when it happens, survivors often feel a surprising mix of…

Read More
how resensation helped a cancer researcher face the odds

Katy designs clinical trials to find better cancer treatments—she knew what her 40% lifetime risk of breast cancer meant.

Read More
More Blog Articles